Lb Pharmaceuticals (LBRX) Current Leases (2024 - 2026)

Lb Pharmaceuticals has reported Current Leases for 3 years, with the latest figure at $730000.0 in Q1 2026.

• For the quarter ending Q1 2026, Current Leases changed N/A year-over-year to $730000.0; the trailing twelve-month figure through Mar 2026 stood at $730000.0 (changed N/A YoY), and the FY2025 full-year result was $730000.0, up 49.9% from the prior year.
• Current Leases for Q1 2026 stood at $730000.0, roughly flat from $730000.0 in the prior quarter.
• The five-year high for Current Leases was $730000.0 in Q3 2025, with the low at $487000.0 in Q4 2024.
• Average Current Leases over 3 years is $669250.0, with a median of $730000.0 recorded in 2025.
• Peak annual rise in Current Leases reached 49.9% in 2025, while the deepest fall reached 49.9% in 2025.
• Tracing LBRX's Current Leases over 3 years: stood at $487000.0 in 2024, then soared by 49.9% to $730000.0 in 2025, then changed by 0.0% to $730000.0 in 2026.
• The last three Current Leases figures came in at $730000.0 (Q1 2026), $730000.0 (Q4 2025), and $730000.0 (Q3 2025), per Business Quant data.

Peer Comparison